Skip to main content

F-star Therapeutics, Inc.

FSTXDelisted Mar 9, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001566373

F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in F-star Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
+13 vs. Q1 2022
Shares held
7.19M
−986.8K (−12.1%) vs. Q1 2022
Total value
$45.1M
+$16.0M (+55.2%) vs. Q1 2022
New holders
21
11 more added
Sold out
8
10 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 53 institutions
Q1 2021: 26 institutionsQ2 2021: 41 institutionsQ3 2021: 37 institutionsQ4 2021: 43 institutionsQ1 2022: 40 institutionsQ2 2022: 53 institutionsQ3 2022: 54 institutionsQ4 2022: 59 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $45.1M
Q1 2021: $19.4MQ2 2021: $93.5MQ3 2021: $71.9MQ4 2021: $53.2MQ1 2022: $29.0MQ2 2022: $45.1MQ3 2022: $35.5MQ4 2022: $57.8MQ1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding FSTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 202259$57.8M
Q3 202254$35.5M
Q2 202253$45.1M
Q1 202240$29.0M
Q4 202143$53.2M
Q3 202137$71.9M
Q2 202141$93.5M
Q1 202126$19.4M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding F-star Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding FSTX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
TCI Wealth Advisors, Inc.300$2.00K0.00%00.0%Unchanged
JPMorgan Chase & Co1,498$9.00K0.00%−19,837−93.0%Reduced
Cannell Capital LLC1,804$11.0K0.00%+1,804New
FNY Investment Advisers, LLC2,000$12.0K0.01%+2,000New
Wolverine Asset Management LLC2,200$13.0K0.00%+2,200New
Total Clarity Wealth Management, Inc.2,000$13.0K0.01%+2,000New
UBS Group AG2,224$14.0K0.00%+2,174+4,348.0%Added
Urban Wealth Management, LLC4,691$29.0K0.10%+4,691New
Advisor Group Holdings, Inc.4,946$31.0K0.00%+619+14.3%Added
Simplex Trading, LLC8,717$54.0K0.00%+8,717New
Bryn Mawr Trust Co10,000$63.0K0.00%00.0%Unchanged
Morgan Stanley10,234$64.0K0.00%−7,807−43.3%Reduced
Charles Schwab Investment Management Inc12,327$78.0K0.00%+12,327New
Silvercrest Asset Management Group LLC12,585$79.0K0.00%00.0%Unchanged
Private Capital Advisors, Inc.13,083$82.0K0.01%00.0%Unchanged
Envestnet Asset Management Inc14,313$90.0K0.00%+749+5.5%Added
Jump Financial, LLC16,500$103.0K0.00%+5,200+46.0%Added
Wolverine Trading, LLC16,351$104.0K0.00%+16,351New
Diametric Capital, LP17,500$110.0K0.08%+17,500New
Goldman Sachs Group Inc20,146$126.0K0.00%−13,656−40.4%Reduced
PenderFund Capital Management Ltd.22,950$185.0K0.05%+22,950New
Northern Trust Corp35,102$220.0K0.00%00.0%Unchanged
Parsons Capital Management Inc36,291$227.0K0.02%+15,000+70.5%Added
Prelude Capital Management, LLC36,278$227.0K0.01%+36,278New
TD Asset Management Inc39,687$248.0K0.00%−18,800−32.1%Reduced
BCK Capital Management LP52,000$326.0K0.25%+52,000New
Connolly Sarah T.53,001$332.0K0.23%00.0%Unchanged
State Street Corp53,150$333.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp53,431$334.0K0.00%+7,679+16.8%Added
Manufacturers Life Insurance Company, The54,981$348.0K0.00%00.0%Unchanged
Formidable Asset Management, LLC61,090$382.0K0.09%+61,090New
Toroso Investments, LLC61,090$382.0K0.01%+61,090New
Knott David M Jr75,454$472.0K0.22%+75,454New
Citigroup Inc78,000$488.0K0.00%+78,000New
Point72 Asset Management, L.P.91,761$574.0K0.00%−758,239−89.2%Reduced
Ergoteles LLC107,420$672.0K0.02%+107,420New
Maven Securities LTD113,859$713.0K0.13%+113,859New
Gabelli & Co Investment Advisers, Inc.115,650$724.0K0.09%+115,650New
Barclays PLC117,058$733.0K0.00%+41,868+55.7%Added
Susquehanna International Group, LLP147,934$926.0K0.00%+147,934New
Renaissance Technologies LLC167,411$1.05M0.00%−81,729−32.8%Reduced
Gabelli Funds LLC168,828$1.06M0.01%+168,828New
Geode Capital Management, LLC178,939$1.12M0.00%+33,508+23.0%Added
Citadel Advisors LLC209,395$1.31M0.00%−83,598−28.5%Reduced
Wells Fargo & Company214,719$1.34M0.00%+214,602+183,420.5%Added
BlackRock Inc.296,853$1.86M0.00%+906+0.3%Added
Russell Investments Group, Ltd.374,550$2.34M0.00%−226,844−37.7%Reduced
Atlas Venture Advisors, Inc.574,996$3.60M1.14%00.0%Unchanged
DAFNA Capital Management LLC576,881$3.61M0.98%−116,904−16.9%Reduced
Atlas Venture Life Science Advisors, LLC599,524$3.75M0.63%00.0%Unchanged
Price T Rowe Associates Inc609,654$3.82M0.00%−179,936−22.8%Reduced
Rock Springs Capital Management LP751,889$4.71M0.14%00.0%Unchanged
Vanguard Group Inc889,253$5.57M0.00%+290,816+48.6%Added
Adage Capital Partners GP, L.L.C.0$00.00%−900,000−100.0%Sold out
Anson Funds Management LP0$00.00%−185,261−100.0%Sold out
Millennium Management LLC0$00.00%−85,834−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−15,865−100.0%Sold out
Marshall Wace, LLP0$00.00%−10,456−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−3,065−100.0%Sold out
Bank of America Corp0$00.00%−162−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−66−100.0%Sold out